AARTI DRUGS
Back to Balance Sheet
|
AARTI DRUGS Last 5 Year Total Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹2,432 Cr | ₹2,421 Cr | ₹2,208 Cr | ₹1,766 Cr | ₹1,577 Cr |
What is the latest Total Liabilities ratio of AARTI DRUGS ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹2,432 Cr |
Mar2023 | ₹2,421 Cr |
Mar2022 | ₹2,208 Cr |
Mar2021 | ₹1,766 Cr |
Mar2020 | ₹1,577 Cr |
How is Total Liabilities of AARTI DRUGS Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹2,432 Cr | 0.45 | |
Mar2023 | ₹2,421 Cr | 9.67 | |
Mar2022 | ₹2,208 Cr | 25.02 | |
Mar2021 | ₹1,766 Cr | 12.02 | |
Mar2020 | ₹1,577 Cr | - |
Compare Total Liabilities of peers of AARTI DRUGS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AARTI DRUGS | ₹3,594.9 Cr | -5.6% | -6.3% | -24.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹407,827.0 Cr | -3.1% | -3.9% | 12.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹157,931.0 Cr | -2.9% | -0.8% | 62.5% | Stock Analytics | |
CIPLA | ₹117,322.0 Cr | 1.1% | 0.3% | 1.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,116.0 Cr | -1.3% | -9.4% | -0.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹94,752.0 Cr | -3.7% | -5.9% | 19.7% | Stock Analytics |
AARTI DRUGS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AARTI DRUGS | -5.6% |
-6.3% |
-24.1% |
SENSEX | -2.9% |
-0.1% |
6.8% |
You may also like the below Video Courses